Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nectin-4 PET to Predict Response to Nectin-4-Targeted Therapy in Advanced Breast Cancer

NCT07708922 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07708922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07708922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nectin-4 PET to Predict Response to Nectin-4-Targeted Therapy in Advanced Breast Cancer
Lead sponsor
Fudan University
Phase
Observational
Overall status
Active, not recruiting
Start date
June 30, 2026
Completion date
December 30, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer metastatic